 | • レポートコード：MRC2-11QY12247 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はヒト胚性幹細胞アッセイのグローバル市場について調査・分析したレポートです。種類別（生存率/細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス）市場規模、用途別（バイオファーマシューティカル・バイオテクノロジー企業、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ヒト胚性幹細胞アッセイの競争状況、市場シェア ・世界のヒト胚性幹細胞アッセイ市場：種類別市場規模 2015年-2020年（生存率/細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス） ・世界のヒト胚性幹細胞アッセイ市場：種類別市場規模予測 2021年-2026年（生存率/細胞毒性、分離・精製、細胞同定、増殖、分化、機能、アポトーシス） ・世界のヒト胚性幹細胞アッセイ市場：用途別市場規模 2015年-2020年（バイオファーマシューティカル・バイオテクノロジー企業、研究所） ・世界のヒト胚性幹細胞アッセイ市場：用途別市場規模予測 2021年-2026年（バイオファーマシューティカル・バイオテクノロジー企業、研究所） ・北米のヒト胚性幹細胞アッセイ市場分析：米国、カナダ ・ヨーロッパのヒト胚性幹細胞アッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのヒト胚性幹細胞アッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のヒト胚性幹細胞アッセイ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのヒト胚性幹細胞アッセイ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Merck、GE Healthcare、Bio-Rad Laboratories、Promega Corporation、Agilent Technologies、Perkinelmer、Miltenyi Biotec、Cell Biolabs、Hemogenix、Stemcell Technologies、Bio-Techne Corporation、Cellular Dynamics International (CDI) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Human Embryonic Stem Cell Assay Market
The global Human Embryonic Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Human Embryonic Stem Cell Assay Scope and Market Size
Human Embryonic Stem Cell Assay market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Embryonic Stem Cell Assay market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher Scientific
Merck
GE Healthcare
Bio-Rad Laboratories
Promega Corporation
Agilent Technologies
Perkinelmer
Miltenyi Biotec
Cell Biolabs
Hemogenix
Stemcell Technologies
Bio-Techne Corporation
Cellular Dynamics International (CDI)
Market segment by Type, the product can be split into
Viability/Cytotoxicity
Isolation & Purification
Cell Identification
Proliferation
Differentiation
Function
Apoptosis
Market segment by Application, split into
Biopharmaceutical & Biotechnology Companies
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Embryonic Stem Cell Assay Revenue
1.4 Market by Type
1.4.1 Global Human Embryonic Stem Cell Assay Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Viability/Cytotoxicity
1.4.3 Isolation & Purification
1.4.4 Cell Identification
1.4.5 Proliferation
1.4.6 Differentiation
1.4.7 Function
1.4.8 Apoptosis
1.5 Market by Application
1.5.1 Global Human Embryonic Stem Cell Assay Market Share by Application: 2020 VS 2026
1.5.2 Biopharmaceutical & Biotechnology Companies
1.5.3 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Human Embryonic Stem Cell Assay Market Perspective (2015-2026)
2.2 Global Human Embryonic Stem Cell Assay Growth Trends by Regions
2.2.1 Human Embryonic Stem Cell Assay Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Human Embryonic Stem Cell Assay Historic Market Share by Regions (2015-2020)
2.2.3 Human Embryonic Stem Cell Assay Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Human Embryonic Stem Cell Assay Market Growth Strategy
2.3.6 Primary Interviews with Key Human Embryonic Stem Cell Assay Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Human Embryonic Stem Cell Assay Players by Market Size
3.1.1 Global Top Human Embryonic Stem Cell Assay Players by Revenue (2015-2020)
3.1.2 Global Human Embryonic Stem Cell Assay Revenue Market Share by Players (2015-2020)
3.1.3 Global Human Embryonic Stem Cell Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Human Embryonic Stem Cell Assay Market Concentration Ratio
3.2.1 Global Human Embryonic Stem Cell Assay Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Human Embryonic Stem Cell Assay Revenue in 2019
3.3 Human Embryonic Stem Cell Assay Key Players Head office and Area Served
3.4 Key Players Human Embryonic Stem Cell Assay Product Solution and Service
3.5 Date of Enter into Human Embryonic Stem Cell Assay Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Embryonic Stem Cell Assay Historic Market Size by Type (2015-2020)
4.2 Global Human Embryonic Stem Cell Assay Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
5.2 Global Human Embryonic Stem Cell Assay Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Human Embryonic Stem Cell Assay Market Size (2015-2020)
6.2 Human Embryonic Stem Cell Assay Key Players in North America (2019-2020)
6.3 North America Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
6.4 North America Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
7 Europe
7.1 Europe Human Embryonic Stem Cell Assay Market Size (2015-2020)
7.2 Human Embryonic Stem Cell Assay Key Players in Europe (2019-2020)
7.3 Europe Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
7.4 Europe Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
8 China
8.1 China Human Embryonic Stem Cell Assay Market Size (2015-2020)
8.2 Human Embryonic Stem Cell Assay Key Players in China (2019-2020)
8.3 China Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
8.4 China Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
9 Japan
9.1 Japan Human Embryonic Stem Cell Assay Market Size (2015-2020)
9.2 Human Embryonic Stem Cell Assay Key Players in Japan (2019-2020)
9.3 Japan Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
9.4 Japan Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Human Embryonic Stem Cell Assay Market Size (2015-2020)
10.2 Human Embryonic Stem Cell Assay Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
10.4 Southeast Asia Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
11 India
11.1 India Human Embryonic Stem Cell Assay Market Size (2015-2020)
11.2 Human Embryonic Stem Cell Assay Key Players in India (2019-2020)
11.3 India Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
11.4 India Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Human Embryonic Stem Cell Assay Market Size (2015-2020)
12.2 Human Embryonic Stem Cell Assay Key Players in Central & South America (2019-2020)
12.3 Central & South America Human Embryonic Stem Cell Assay Market Size by Type (2015-2020)
12.4 Central & South America Human Embryonic Stem Cell Assay Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific Human Embryonic Stem Cell Assay Introduction
13.1.4 Thermo Fisher Scientific Revenue in Human Embryonic Stem Cell Assay Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Human Embryonic Stem Cell Assay Introduction
13.2.4 Merck Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.2.5 Merck Recent Development
13.3 GE Healthcare
13.3.1 GE Healthcare Company Details
13.3.2 GE Healthcare Business Overview
13.3.3 GE Healthcare Human Embryonic Stem Cell Assay Introduction
13.3.4 GE Healthcare Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.3.5 GE Healthcare Recent Development
13.4 Bio-Rad Laboratories
13.4.1 Bio-Rad Laboratories Company Details
13.4.2 Bio-Rad Laboratories Business Overview
13.4.3 Bio-Rad Laboratories Human Embryonic Stem Cell Assay Introduction
13.4.4 Bio-Rad Laboratories Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.4.5 Bio-Rad Laboratories Recent Development
13.5 Promega Corporation
13.5.1 Promega Corporation Company Details
13.5.2 Promega Corporation Business Overview
13.5.3 Promega Corporation Human Embryonic Stem Cell Assay Introduction
13.5.4 Promega Corporation Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.5.5 Promega Corporation Recent Development
13.6 Agilent Technologies
13.6.1 Agilent Technologies Company Details
13.6.2 Agilent Technologies Business Overview
13.6.3 Agilent Technologies Human Embryonic Stem Cell Assay Introduction
13.6.4 Agilent Technologies Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.6.5 Agilent Technologies Recent Development
13.7 Perkinelmer
13.7.1 Perkinelmer Company Details
13.7.2 Perkinelmer Business Overview
13.7.3 Perkinelmer Human Embryonic Stem Cell Assay Introduction
13.7.4 Perkinelmer Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.7.5 Perkinelmer Recent Development
13.8 Miltenyi Biotec
13.8.1 Miltenyi Biotec Company Details
13.8.2 Miltenyi Biotec Business Overview
13.8.3 Miltenyi Biotec Human Embryonic Stem Cell Assay Introduction
13.8.4 Miltenyi Biotec Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.8.5 Miltenyi Biotec Recent Development
13.9 Cell Biolabs
13.9.1 Cell Biolabs Company Details
13.9.2 Cell Biolabs Business Overview
13.9.3 Cell Biolabs Human Embryonic Stem Cell Assay Introduction
13.9.4 Cell Biolabs Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.9.5 Cell Biolabs Recent Development
13.10 Hemogenix
13.10.1 Hemogenix Company Details
13.10.2 Hemogenix Business Overview
13.10.3 Hemogenix Human Embryonic Stem Cell Assay Introduction
13.10.4 Hemogenix Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
13.10.5 Hemogenix Recent Development
13.11 Stemcell Technologies
10.11.1 Stemcell Technologies Company Details
10.11.2 Stemcell Technologies Business Overview
10.11.3 Stemcell Technologies Human Embryonic Stem Cell Assay Introduction
10.11.4 Stemcell Technologies Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
10.11.5 Stemcell Technologies Recent Development
13.12 Bio-Techne Corporation
10.12.1 Bio-Techne Corporation Company Details
10.12.2 Bio-Techne Corporation Business Overview
10.12.3 Bio-Techne Corporation Human Embryonic Stem Cell Assay Introduction
10.12.4 Bio-Techne Corporation Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
10.12.5 Bio-Techne Corporation Recent Development
13.13 Cellular Dynamics International (CDI)
10.13.1 Cellular Dynamics International (CDI) Company Details
10.13.2 Cellular Dynamics International (CDI) Business Overview
10.13.3 Cellular Dynamics International (CDI) Human Embryonic Stem Cell Assay Introduction
10.13.4 Cellular Dynamics International (CDI) Revenue in Human Embryonic Stem Cell Assay Business (2015-2020)
10.13.5 Cellular Dynamics International (CDI) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Human Embryonic Stem Cell Assay Key Market Segments
Table 2. Key Players Covered: Ranking by Human Embryonic Stem Cell Assay Revenue
Table 3. Ranking of Global Top Human Embryonic Stem Cell Assay Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Human Embryonic Stem Cell Assay Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Viability/Cytotoxicity
Table 6. Key Players of Isolation & Purification
Table 7. Key Players of Cell Identification
Table 8. Key Players of Proliferation
Table 9. Key Players of Differentiation
Table 10. Key Players of Function
Table 11. Key Players of Apoptosis
Table 12. Global Human Embryonic Stem Cell Assay Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Human Embryonic Stem Cell Assay Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Human Embryonic Stem Cell Assay Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Human Embryonic Stem Cell Assay Market Share by Regions (2015-2020)
Table 16. Global Human Embryonic Stem Cell Assay Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Human Embryonic Stem Cell Assay Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Human Embryonic Stem Cell Assay Market Growth Strategy
Table 22. Main Points Interviewed from Key Human Embryonic Stem Cell Assay Players
Table 23. Global Human Embryonic Stem Cell Assay Revenue by Players (2015-2020) (Million US$)
Table 24. Global Human Embryonic Stem Cell Assay Market Share by Players (2015-2020)
Table 25. Global Top Human Embryonic Stem Cell Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Embryonic Stem Cell Assay as of 2019)
Table 26. Global Human Embryonic Stem Cell Assay by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Human Embryonic Stem Cell Assay Product Solution and Service
Table 29. Date of Enter into Human Embryonic Stem Cell Assay Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 32. Global Human Embryonic Stem Cell Assay Market Size Share by Type (2015-2020)
Table 33. Global Human Embryonic Stem Cell Assay Revenue Market Share by Type (2021-2026)
Table 34. Global Human Embryonic Stem Cell Assay Market Size Share by Application (2015-2020)
Table 35. Global Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 36. Global Human Embryonic Stem Cell Assay Market Size Share by Application (2021-2026)
Table 37. North America Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 39. North America Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 40. North America Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 41. North America Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 42. North America Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 43. Europe Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 45. Europe Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 47. Europe Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 49. China Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 50. China Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 51. China Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 52. China Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 53. China Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 54. China Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 55. Japan Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 57. Japan Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 59. Japan Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 63. Southeast Asia Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 65. Southeast Asia Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 67. India Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 68. India Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 69. India Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 70. India Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 71. India Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 72. India Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Human Embryonic Stem Cell Assay Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Human Embryonic Stem Cell Assay Market Share (2019-2020)
Table 75. Central & South America Human Embryonic Stem Cell Assay Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Human Embryonic Stem Cell Assay Market Share by Type (2015-2020)
Table 77. Central & South America Human Embryonic Stem Cell Assay Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Human Embryonic Stem Cell Assay Market Share by Application (2015-2020)
Table 79. Thermo Fisher Scientific Company Details
Table 80. Thermo Fisher Scientific Business Overview
Table 81. Thermo Fisher Scientific Product
Table 82. Thermo Fisher Scientific Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 83. Thermo Fisher Scientific Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. GE Healthcare Company Details
Table 90. GE Healthcare Business Overview
Table 91. GE Healthcare Product
Table 92. GE Healthcare Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 93. GE Healthcare Recent Development
Table 94. Bio-Rad Laboratories Company Details
Table 95. Bio-Rad Laboratories Business Overview
Table 96. Bio-Rad Laboratories Product
Table 97. Bio-Rad Laboratories Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 98. Bio-Rad Laboratories Recent Development
Table 99. Promega Corporation Company Details
Table 100. Promega Corporation Business Overview
Table 101. Promega Corporation Product
Table 102. Promega Corporation Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 103. Promega Corporation Recent Development
Table 104. Agilent Technologies Company Details
Table 105. Agilent Technologies Business Overview
Table 106. Agilent Technologies Product
Table 107. Agilent Technologies Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 108. Agilent Technologies Recent Development
Table 109. Perkinelmer Company Details
Table 110. Perkinelmer Business Overview
Table 111. Perkinelmer Product
Table 112. Perkinelmer Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 113. Perkinelmer Recent Development
Table 114. Miltenyi Biotec Business Overview
Table 115. Miltenyi Biotec Product
Table 116. Miltenyi Biotec Company Details
Table 117. Miltenyi Biotec Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 118. Miltenyi Biotec Recent Development
Table 119. Cell Biolabs Company Details
Table 120. Cell Biolabs Business Overview
Table 121. Cell Biolabs Product
Table 122. Cell Biolabs Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 123. Cell Biolabs Recent Development
Table 124. Hemogenix Company Details
Table 125. Hemogenix Business Overview
Table 126. Hemogenix Product
Table 127. Hemogenix Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 128. Hemogenix Recent Development
Table 129. Stemcell Technologies Company Details
Table 130. Stemcell Technologies Business Overview
Table 131. Stemcell Technologies Product
Table 132. Stemcell Technologies Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 133. Stemcell Technologies Recent Development
Table 134. Bio-Techne Corporation Company Details
Table 135. Bio-Techne Corporation Business Overview
Table 136. Bio-Techne Corporation Product
Table 137. Bio-Techne Corporation Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 138. Bio-Techne Corporation Recent Development
Table 139. Cellular Dynamics International (CDI) Company Details
Table 140. Cellular Dynamics International (CDI) Business Overview
Table 141. Cellular Dynamics International (CDI) Product
Table 142. Cellular Dynamics International (CDI) Revenue in Human Embryonic Stem Cell Assay Business (2015-2020) (Million US$)
Table 143. Cellular Dynamics International (CDI) Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Embryonic Stem Cell Assay Market Share by Type: 2020 VS 2026
Figure 2. Viability/Cytotoxicity Features
Figure 3. Isolation & Purification Features
Figure 4. Cell Identification Features
Figure 5. Proliferation Features
Figure 6. Differentiation Features
Figure 7. Function Features
Figure 8. Apoptosis Features
Figure 9. Global Human Embryonic Stem Cell Assay Market Share by Application: 2020 VS 2026
Figure 10. Biopharmaceutical & Biotechnology Companies Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Human Embryonic Stem Cell Assay Report Years Considered
Figure 13. Global Human Embryonic Stem Cell Assay Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Human Embryonic Stem Cell Assay Market Share by Regions: 2020 VS 2026
Figure 15. Global Human Embryonic Stem Cell Assay Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Human Embryonic Stem Cell Assay Market Share by Players in 2019
Figure 18. Global Top Human Embryonic Stem Cell Assay Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Embryonic Stem Cell Assay as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Embryonic Stem Cell Assay Revenue in 2019
Figure 20. North America Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Human Embryonic Stem Cell Assay Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
成体幹細胞アッセイの世界市場（～2026年） Market Analysis and Insights: Global Adult Stem Cell Assay Market The global Adult Stem Cell Assay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adult Stem Cell Assay Scope and Market Size Adult Stem Cell Assay marke…- 幹細胞アッセイの世界市場（～2026年） The demand of global stem cell assay is increasing. Market Analysis and Insights: Global Stem Cell Assay Market The global Stem Cell Assay market size is projected to reach US$ 843 million by 2026, from US$ 750.5 million in 2020, at a CAGR of 11.4%% during 2021-2026. Global Stem Cell Assay Scope and…
- ヒト間葉系幹細胞（hMSC）の世界市場（～2026年） Human mesenchymal stem cells (hMSC) are multipotent stromal cells that can differentiate into a variety of cell types. Market Analysis and Insights: Global Human Mesenchymal Stem Cells (hMSC) Market The global Human Mesenchymal Stem Cells (hMSC) market size is projected to reach US$ XX million by 20…
- 自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…
- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…